29A4 Gomella, Leonard - Thomas Jefferson University - Thomas Jefferson University

Leonard Gomella, MD

Contact Dr. Gomella

1025 Walnut Street
Suite 1112
Philadelphia, PA 19107

(215) 955-6961
(215) 923-1884 fax

Most Recent Peer-reviewed Publications

  1. Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk
  2. Editorial Commentary
  3. VPAC1 targeted 64Cu-TP3805 positron emission tomography imaging of prostate cancer: Preliminary evaluation in man
  4. Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer
  5. Radical Retropubic Prostatectomy
  6. Survival outcomes of sipuleucel-T phase III studies: Impact of control-arm cross-over to salvage immunotherapy
  7. Structure-based screen identifies a potent small molecule inhibitor of Stat5a/b with therapeutic potential for prostate cancer and chronic myeloid leukemia
  8. Risk factors for biochemical recurrence after robotic assisted radical prostatectomy: A single surgeon experience
  9. Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy
  10. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- And tissue-specific microRNAs
  11. Novel actions of next-generation taxanes benefit advanced stages of prostate cancer
  12. Duration of androgen suppression before radiotherapy for localized prostate cancer: Radiation therapy oncology group randomized clinical trial 9910
  13. A randomised, double-blind study comparing the addition of bicalutamide with or without dutasteride to GnRH analogue therapy in men with non-metastatic castrate-resistant prostate cancer
  14. Robotic and open radical prostatectomy: Celebrating oncologic equivalence
  15. When 4 does not mean 4: A patient portal lesson
  16. Upfront chemo for PCA? Yes, but...
  17. A phase 3 trial of 2 years of androgen suppression and radiation therapy with or without adjuvant chemotherapy for high-risk prostate cancer: Final results of radiation therapy oncology group phase 3 randomized trial NRG oncology RTOG 9902
  18. Analyzing the FHIT gene by RT-PCR, western blotting, and immunohistochemistry
  19. Editorial
  20. A novel role for drebrin in regulating progranulin bioactivity in bladder cancer